BELLEVICINE, CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 6.037
NA - Nord America 5.141
EU - Europa 4.231
SA - Sud America 649
AF - Africa 142
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 16.211
Nazione #
US - Stati Uniti d'America 4.938
SG - Singapore 2.605
RU - Federazione Russa 2.016
VN - Vietnam 1.152
CN - Cina 1.102
IT - Italia 967
HK - Hong Kong 551
BR - Brasile 529
DE - Germania 294
FR - Francia 200
NL - Olanda 169
FI - Finlandia 153
IN - India 141
CA - Canada 114
GB - Regno Unito 100
IE - Irlanda 79
JP - Giappone 75
BD - Bangladesh 71
KR - Corea 56
MX - Messico 54
AR - Argentina 50
ES - Italia 44
PL - Polonia 43
PH - Filippine 38
CI - Costa d'Avorio 37
IQ - Iraq 37
ZA - Sudafrica 37
TH - Thailandia 36
UA - Ucraina 36
EC - Ecuador 26
ID - Indonesia 22
LT - Lituania 21
SE - Svezia 21
AT - Austria 20
TR - Turchia 18
EG - Egitto 17
PK - Pakistan 16
IR - Iran 15
JO - Giordania 13
TW - Taiwan 13
VE - Venezuela 12
UZ - Uzbekistan 11
CO - Colombia 10
DZ - Algeria 9
IL - Israele 8
RO - Romania 8
BE - Belgio 7
CZ - Repubblica Ceca 7
KE - Kenya 7
RS - Serbia 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
JM - Giamaica 6
PE - Perù 6
CL - Cile 5
ET - Etiopia 5
MA - Marocco 5
MY - Malesia 5
PY - Paraguay 5
SY - Repubblica araba siriana 5
TN - Tunisia 5
CR - Costa Rica 4
KZ - Kazakistan 4
OM - Oman 4
PT - Portogallo 4
XK - ???statistics.table.value.countryCode.XK??? 4
AZ - Azerbaigian 3
GR - Grecia 3
LB - Libano 3
MN - Mongolia 3
NG - Nigeria 3
NP - Nepal 3
TT - Trinidad e Tobago 3
AD - Andorra 2
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
GE - Georgia 2
GN - Guinea 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HT - Haiti 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
Totale 16.171
Città #
Singapore 1.237
San Jose 1.063
Hong Kong 528
Moscow 492
Chandler 427
Ashburn 417
Beijing 342
Ho Chi Minh City 319
Hanoi 277
Naples 243
Hefei 166
Los Angeles 157
Santa Clara 155
The Dalles 150
Lauterbourg 139
Millbury 137
Amsterdam 128
Napoli 120
Munich 111
Des Moines 78
New York 71
Princeton 71
Boston 69
Tokyo 64
Nanjing 63
Redondo Beach 58
São Paulo 56
Buffalo 52
Lawrence 51
Orem 48
Dallas 47
Haiphong 47
Wilmington 46
Frankfurt am Main 45
Helsinki 44
Da Nang 43
Rome 39
Seoul 35
Warsaw 35
Milan 34
Montreal 34
Turku 34
Kochi 33
Ottawa 31
Atlanta 29
Biên Hòa 28
Seattle 28
Brooklyn 26
Chennai 26
Chicago 26
Council Bluffs 25
Nanchang 25
Rio de Janeiro 25
Falkenstein 23
Mexico City 23
Nuremberg 23
Hebei 21
London 21
Denver 19
San Giovanni Rotondo 19
Johannesburg 18
Stockholm 18
Baghdad 17
Toronto 17
Dong Ket 16
Houston 16
Poplar 16
Changsha 15
Hải Dương 15
Bangkok 13
Jiaxing 13
Lappeenranta 13
New Delhi 13
Salerno 13
Thái Nguyên 13
Amman 12
Can Tho 12
Falls Church 12
Phoenix 12
Redwood City 12
Tianjin 12
Belo Horizonte 11
Dublin 11
San Francisco 11
Cairo 10
Guayaquil 10
Tashkent 10
Tehran 10
Valencia 10
Guangzhou 9
Philadelphia 9
Pune 9
Salt Lake City 9
Shenyang 9
Vienna 9
Dhaka 8
Düsseldorf 8
Fairfield 8
Manchester 8
Messina 8
Totale 8.698
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 222
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 186
Thyroid Cancer and Fibroblasts 182
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 182
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts 176
Analysis of human primary fibroblast spheroids 172
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 171
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation 170
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 164
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 162
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 162
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 155
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 154
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 154
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 154
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 153
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 150
Potential involvement of neutrophils in human thyroid cancer 150
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 150
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 149
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 148
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 147
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 147
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 145
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 143
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 142
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 141
Foxe1 gene dosage affects thyroid cancer histology and differentiation in vivo 141
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 138
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 137
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 136
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 136
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 135
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 134
Herbal hepatotoxicity: a case of difficult interpretation. 133
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 133
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. 132
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 132
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 130
Pure primary squamous cell carcinoma of the breast presenting as an intracystic tumor. 129
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 129
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 129
Next generation sequencing in cytology 129
CD10 is useful to identify gastrointestinal contamination in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology from pancreatic ductal adenocarcinoma. 128
Role of Cytomorphology in the Era of Liquid Biopsy 128
Predictive molecular pathology in the time of COVID-19 128
Methods for actionable gene fusion detection in lung cancer: now and in the future 128
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 125
EGFR mutation detection by microfluidic technology: a validation study. 125
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 123
A novel approach to classification and reporting of lymph node fine-needle cytology: Application of the proposed sydney system 123
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 122
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 122
Brca1/2 ngs somatic testing in clinical practice: a short report 121
UbcH10 overexpression is less pronounced in older colorectal cancer patients 120
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 120
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 119
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 119
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 119
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 118
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 117
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 117
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 117
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 116
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 116
PD-L1 and beyond: Immuno-oncology in cytopathology 116
Applications and limitations of oncogene mutation testing in clinical cytopathology. 115
Biopsic Sampling (cancer) comprehensive sampling and sample preparation 114
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 113
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 113
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy). 113
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 113
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 113
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 113
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 113
Impact assessment of the implementation of an integrated care model for thyroid disease at the university hospital “federico ii” of naples (Campania region, southern italy): An interrupted time series analysis 112
Interobserver variability in cytopathology: How much do we agree? 111
How should a follicular adenoma with papillary architecture be classified on thyroid FNA? Case report with histological correlation 111
Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature. 111
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 111
PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates. 110
EGFR analysis: Current evidence and future directions 110
How to prepare cytological samples for molecular testing 110
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 110
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 110
Multicentric encapsulated papillary oncocytic neoplasm of the thyroid: A case diagnosed by a combined cytological, histological, immunohistochemical, and molecular approach 108
Cytological and Molecular Features of PapillaryThyroid Carcinoma with Prominent Hobnail Features:A Case Report 107
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 106
Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: A histochemical, immunohistochemical, and molecular report 106
Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? 104
MicroRNA profiling predicts positive nodal status in papillary thyroid carcinoma in the preoperative setting 103
Kras Testing On Cytologic Imprints of Colo-rectal Carcinoma 103
Cytologically undetermined follicular lesions: surgical procedures and histological outcome in 472 cases. 101
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 100
Navigating the Diagnostic Challenges in Lymph Node Cytology: The Case of Reactive Hyperplasia 99
In Vivo Histological Assessment of a Spontaneous Coronary Artery Dissection 99
EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study 98
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 98
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 96
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 96
Totale 12.901
Categoria #
all - tutte 51.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 12 19
2021/2022754 12 13 8 11 9 16 14 43 78 63 172 315
2022/20231.101 131 56 41 83 142 118 5 118 201 123 65 18
2023/2024730 39 137 91 48 30 50 6 88 23 33 106 79
2024/20254.420 199 235 8 23 114 213 437 272 284 560 1.706 369
2025/20268.437 877 565 870 737 1.476 395 1.124 434 1.057 616 286 0
Totale 16.517